Related Experiment Video
Updated: Mar 13, 2026
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins
Matthew M Dooley1, Samantha L de Gannes1, Kristi A Fu1
1Department of Neurology, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA.
Abstract:
Multiple sclerosis (MS) is associated with Epstein-Barr virus (EBV) infection, and the antibody response to EBV is reported to be increased in MS. EBV contains multiple antigens, and only a few have been investigated. Our hypothesis is that MS patients will have an increased antibody response to only selected EBV antigens. We used immunoprecipitation and quantitative mass spectrometry to identify candidate EBV antigens. We then measured the antibody response to 10 individual EBV proteins with quantitative ELISA. We found that the antibody response was increased in MS to three of the EBV proteins, but not to the other seven.
Insights
Multiple sclerosis (MS) patients show increased antibodies to specific Epstein-Barr virus (EBV) proteins. This study identified three key EBV antigens with heightened antibody responses in MS, advancing our understanding of the virus-disease link.
Area of Science:
- Immunology
- Virology
- Neuroimmunology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with a known association with Epstein-Barr virus (EBV) infection.
- Previous studies indicate an elevated antibody response to EBV in individuals with MS.
- However, the specific EBV antigens driving this response remain largely uncharacterized.
Purpose of the Study:
- To investigate the hypothesis that MS patients exhibit an increased antibody response to a select subset of EBV antigens.
- To identify specific EBV proteins that elicit a differential antibody response in MS patients compared to controls.
Main Methods:
- Utilized immunoprecipitation and quantitative mass spectrometry to identify potential EBV antigen targets.
- Quantified the antibody response against 10 individual EBV proteins using enzyme-linked immunosorbent assay (ELISA).
Main Results:
- A significantly increased antibody response was observed in MS patients against three specific EBV proteins.
- No significant difference in antibody response was detected for the remaining seven EBV proteins tested.
- This suggests a targeted, rather than generalized, antibody response to EBV in multiple sclerosis.
Conclusions:
- The findings support a specific association between antibodies to certain EBV antigens and multiple sclerosis.
- Highlights the importance of investigating individual viral antigens rather than the virus as a whole in disease associations.
- Further research into these specific EBV antigens may offer new insights into MS pathogenesis and potential therapeutic targets.
Related Concept Videos
00:42Cross-reactivity
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...